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Editors’ Note: In response to “Acute Zika infection
with concurrent onset of Guillain-Barre´ syndrome,”
Dr. Ge´rardin et al. suggest that Zika-related Guillain-Barre´
syndrome (GBS) may have a different mechanism than
postviral GBS. They discuss potential hyperacute immune
response in patients who are dengue seropositive or direct
neurotropic effect as possible mechanisms of action.
Timmings et al., authors of the article, explain that in their
patient and based on clinical data, they favor a direct
pathogenic Zika virus effect on peripheral nerves.
Dr. Avasarala asks several questions about the methods
of the study and interpretation of the results in “Gray matter
MRI differentiates neuromyelitis optica from multiple sclerosis
using random forest.” Authors Eshaghi and Ciccarelli answer
the questions and make clarifications. They add that the
random forest technique is nonparametric and is more
robust to the effect of outliers in comparison with other
methods.
—Chafic Karam, MD, and Robert C. Griggs, MD
LETTER RE: ACUTE ZIKA INFECTION WITH
CONCURRENT ONSET OF GUILLAIN-BARRÉ
SYNDROME
Patrick Gérardin, Saint-Pierre, Réunion; Van-Mai
Cao-Lormeau, Papeete, French Polynesia; Patrice
Tournebize, Saint-Pierre, Réunion; Thomas
Cerny, Zurich, Switzerland: Siu et al.1 reported the
concurrent onset of polyradiculoneuritis and acute
Zika virus (ZIKV) infection, while the virus was not
cleared from the serum. Guillain-Barré syndrome
(GBS) is usually described as a postinfectious disease
during which progressive flaccid paralysis develops
after a phase of latency following infection. In the most
common pathogenetic framework, this free interval
permits the generation of sufficient levels of antibodies
that cross-react by molecular mimicry with specific
components of peripheral nerves, causing myelin or
axonal injury, as previously documented with ZIKV
infection.2 However, this case report suggested other
mechanisms. Given ZIKV cross-reactivity with dengue
virus and increasing reports of ZIKV-associated GBS
in dengue-seropositive patients,1,3 a hyperacute
immune response is possible.4 Given prolonged ZIKV
shedding in bodily fluids, and the overlap between
GBS onset and persistent shedding in fomites, a direct
viral neuropathic effect may also contribute to ZIKV-
associated GBS.4 Indeed, ZIKV is able to infect cranial
neural crest cells that stem Schwann cell formation.5
ZIKV-associated GBS could reflect a direct viral neu-
ropathic effect on the blood–nerve barrier, allowing
cross-reactive antibodies formed during previous in-
fections to have a deleterious effect on nerve function.
1. Siu R, Bukhari W, Todd A, et al. Acute Zika infection with
concurrent onset of Guillain-Barré syndrome. Neurology
2016;87:1623–1624.
2. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré
syndrome outbreak associated with Zika virus infection in
French Polynesia: a case-control study. Lancet 2016;387:
1531–1539.
3. Parra B, Lizarazo J, Jimenez-Arango JA, et al. Guillain-Barré
syndrome associated with Zika virus in Colombia. N Engl J
Med 2016;375:1513–1523.
4. Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue
virus sero-cross-reactivity drives antibody dependent
enhancement of infection with Zika virus. Nat Immunol
2016;17:1102–1108.
5. Bayless NL, Greenberg RS, Swigut T, Wysocka J, Blish CA.
Zika virus infection induces cranial neural crest cells to pro-
duce cytokines at levels detrimental for neurogenesis. Cell
Host Microbe 2016;20:423–428.
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AUTHOR RESPONSE: ACUTE ZIKA INFECTION
WITH CONCURRENT ONSET OF GUILLAIN-BARRÉ
SYNDROME
Paul L. Timmings, Ronald Siu, Wajih
Bukhari, Hamilton; New Zealand; Angela Todd,
Wendy Gunn, Upper Hutt, New Zealand: We
thank Gérardin et al. for the comments on our Clin-
ical/Scientific Note on Zika virus (ZIKV).1 Our
patient was of particular interest because he had an
illness clinically and electrophysiologically indistin-
guishable from Guillain-Barré syndrome (GBS) that
developed within a few days of acute ZIKV infection,
in the context of contemporaneous Zika viremia.1
Concurrently obtained CSF was negative for ZIKV.
Brain and spine MRI were also normal. Importantly,
there was no serologic evidence of priming by pre-
vious dengue or other flaviviruses.
These clinical data suggested a direct ZIKV neural
injury mechanism, without a requirement for prim-
ing. We postulated that although molecular mimicry
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between ZIKV and peripheral nerve components
might be relevant to antibody-induced GBS, such
a rapidly developing polyradiculoneuritis mimicking
GBS might also have been mediated by a direct path-
ogenic ZIKV effect on peripheral nerves.2,3 This
observation and ZIKV neurotropism may also
account for delayed CNS ZIKV effects in some pa-
tients. The fact that our patient was ZIKV-negative in
CSF suggests efficacy of the blood–brain barrier to
ZIKV at that time point and strengthens the sug-
gestion that ZIKV CNS invasion may be via neuronal
transmission rather than directly across the blood–
brain barrier.
1. Siu R, Bukhari W, Todd A, et al. Acute Zika infection with
concurrent onset of Guillain-Barré syndrome. Neurology
2016;87:1623–1624.
2. Neal JW. Flaviviruses are neurotropic, but how do they
invade the CNS? J Infect 2014;69:203–215.
3. Velandia ML, Castellanos JE. Flavivirus neurotropism, neu-
roinvasion, neurovirulence and neurosusceptibility: clues to
understanding flavivirus- and dengue-induced encephalitis.
In: Garcia ML, Romanowski V, editors. Viral Genomes:
Molecular Structure, Diversity, Gene Expression Mecha-
nisms and Host-virus Interactions. Rijeka: InTech; 2012:
219–240.
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LETTER RE: GRAY MATTER MRI DIFFERENTIATES
NEUROMYELITIS OPTICA FROM MULTIPLE
SCLEROSIS USING RANDOM FOREST
Jagannadha Avasarala, Greenville, NC: The article
by Eshaghi et al.1 gave a glimpse of where neuroradi-
ology is headed. Pertinent questions include the
following:
Did the algorithm miss aquaporin-4 autoantibody-
positive cases? If so, what were the false-negative
numbers?
Did this model pick up disease at the earliest stage
of evolution, since treatment options could be insti-
tuted earlier? Also, as opposed to autoantibody (Ab)
testing for neuromyelitis optica spectrum disorder
(NMOSD), algorithms probably suffered from poor
specificity at the earliest stages of disease evolution
unless it was shown across patient cohorts that corti-
cal atrophy and deep gray matter changes occur very
early.
Since clinical evaluation is the only option to
diagnose Ab-negative NMOSD, how was the gold
standard set up? Was the Ab-negative NMOSD
cohort set up after evaluation by experts in
neuroimmunology?
Would specificity of the algorithm suffer as disabil-
ity worsens? For example, is it possible that cases in
the secondary progressive multiple sclerosis stage
would overlap with NMOSD as far as deep gray mat-
ter atrophy is concerned?
It is possible that algorithms are not sensitive at the
outliers or extremes of a bell curve and, therefore, lim-
ited in clinical setting utility? The more pressing ques-
tion: How early can these changes be correctly
identified?
1. Eshaghi A, Wottschel V, Cortese R, et al. Gray matter MRI
differentiates neuromyelitis optica from multiple sclerosis
using random forest. Neurology 2016;87:2463–2470.
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AUTHOR RESPONSE: GRAY MATTER MRI
DIFFERENTIATES NEUROMYELITIS OPTICA
FROM MULTIPLE SCLEROSIS USING RANDOM
FOREST
Arman Eshaghi, Olga Ciccarelli, London:We thank
Dr. Avasarala for the comment on our article.1 Since
the majority of patients with neuromyelitis optica
(NMO) were positive for anti-aquaporin-4 autoanti-
body, the classification results (table 2)1 are expected to
remain similar after excluding seronegative patients
(negative predictive value 76%). This is expected as
patients with multiple sclerosis (MS) and NMO are
heterogeneous in clinical and MRI assessments, and
volumes in different brain regions may overlap (figure
1).1 Including other features, such as spinal cord
atrophy, may increase the accuracy.2
We included patients with a secure diagnosis,
meaning the disease duration on average was 7.5
years (table 1).1 Therefore, we cannot comment on
the earliest stages of NMO spectrum disorder. We
previously applied a similar method to patients with
clinically isolated syndrome to predict future evolu-
tion to relapsing-remitting multiple sclerosis
(RRMS).3 The gold standard was clinical diagnosis
by an expert neurologist in each center according to
the Wingerchuk et al.4 2006 criteria. We cannot
exclude false-negative anti-aquaporin-4 autoanti-
body patients, but similar results were obtained
when only seropositive NMO patients and when
all seropositive and seronegative NMO patients were
included.
Although this study only included patients with
RRMS,1 we expect to see increased accuracy if the
algorithm distinguished between patients with sec-
ondary progressive MS (SPMS) and NMO. Patients
with SPMS have a longer disease duration, which
increases atrophy in gray matter.5 This will make it
easier to distinguish SPMS and NMO. Outliers can
have an effect on the performance of the machine
learning techniques. However, random forest tech-
nique is nonparametric, and is more robust to the
effect of outliers in comparison with other
methods.6
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